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The prognostic value of intravenous dipyridamole myocardial
perfusion imaging has not been studied in a large series of elderly
patients. Patients ?70 years of age with known or suspected
coronary artery disease were evaluated to determine the predic-
tive value of intravenous dipyridamole thallium-201 Imaging for
subsequent cardiac death or nonfatal myocardial infarction . Of
the 348 patients, 207 were symptomatic and 141 were asympto-
matic ; 52% of the asymptomatic group had documented coronary
r'y disease . Dorine, 23 x 15 months of follow-up, there were 52
cardiac deaths, 24 nonfatal myocardial infarctions and 42 reves-
cularizatis. procedures (percutaneous translundnal coronary on-
gioplasty in 20
; coronary artery bypass surgery In 22). Clinical
univariate predictors of a cardiac event included previous myo-
rardiat infarction, congestive heart failure symptoms, hypereho-
lesterolemia and diabetes (all p < 0.05).
The presence of a fixed, reversible or combined thallium-201
defect was significantly associated with the occurrence of cardiac
death or myocardial infarction during follow-up (p < 0.05).
In this century, the average life expectancy has increased
from a mean of 47 years to nearly 75 years (1). Clinical
management strategies in elderly patients have become
increasingly more aggressive, with the goals of improving
quality of life and furctional capacity and decreasing cardiac
morbidity and mortality (2-6) .
Coronary artery disease
remains the leading cause of morbid and fatal events in this
age group (7-IO) . Evaluation of the elderly patient must
consider the risk of adverse cardiac events initiated by
aggressive diagnostic evaluation and subsequent therapy .
Historically, exercise thallium-201 myocardial imaging
has demonstrated prognostic value in the assessment of
known or suspected coronary artery disease in patients of
various ages (I1-22) . Abnormal findings on an exercise
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Cardiac death or nonfatal myocardial infarction occurred in only
7 (5%) of 150 patients with a normal dipyridamole thallium-207
study (p < 0.001). Stepwise logistic regression analysis of clinical
and radionuclide variables revealed that an abnormal (reversible
or fixed) dipyridamole thallium-201 study was the single best
predictor of cardiac events (relative risk 7 .2, p < 0.001). As has
been demonstrated in younger patients, previous myocardial
infarction (relative risk 1 .8, p < 0.001) and symptoms of conges-
tive heart failure at presentation (relative risk 1 .6, p = 0.02) were
also significant independent clinical predictors of cardiac death or
myocardial infarction.
Dipyridamole thallium-201 myocardial imaging is a powerful
independent noninvasive technique for prognostication in The
elderly, a group with Limited exercise capacity, the potential for
advanced coronary artery disease and a high risk for cardiac
events .
(J Am Colt C"of
1992;19.-13
.98-8)
electrocardiogram (ECG), exercise-induced thallium-201
perfusion defects, a blunted or diminished hemodynamic
response and impaired cardiac reserve have significant prog-
nostic value in various patient subsets (15,17-19,21) .
Pharmacologic stress has emerged as an effective strategy
for the evaluation of subjects with known or suspected
coronary artery disease (23-31) . Combined analysis of dipyr-
idamole test results and clinical data has been useful in
identifying high risk patient subsets (23-31) . The utility of
clinical and scintigraphic risk stratification in patients >65
years of age has received limited attention (13,20) .
Although elderly patients are commonly referred for
evaluation of known or suspected coronary artery disease
and are frequently limited in their capacity to perform
exercise stress, no previous reports have specifically fo-
cused on the assessment of these older (?70 years) patients
with dipyridamole thallium-201 imaging . This investigation
attempted to determine the prognostic significance of dipyr .
idamole thallium-201 testing in this elderly patient subset and
to establish guidelines for the application of drug stress
myocardial imaging in the clinical management of elderly
patients.
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Methods
Study patients . Consecutively tested patients ?70 years
of age referred to the Saint Louis University Medical Center
for intravenous dipyridamole thallium-20i imaging from Au-
gust I, 1984 to June I . 1989 were retrospectively evaluated .
Of the 354 patients identified, clinical follow-up information
was available in 348 patients (95%) . A total of 93 patients
(26%) have been included in previous reports froT: this
institution (31,32) .
Procedure and Design
Dipyridamole infusion protocol. All dipyridamole infu-
sions were performed in the morning with the patient fasting .
Preinfusion heart rate, 12-lead ECG and blood pressure
measurements were obtained with the patient in the supine
and sitting positions . After baseline measurements were
recorded, dipyridamole was infused at a rate of 0.56 mg/kg
body weight over 4 min through an indwelling intravenous
catheter (30,31) . The 12-lead ECG, heart rate and blood
pressure were monitored every minute for a total of 10 min
from the start of infusion . After dipyridamole infusion, the
patient assumed the sitting position and began active leg
swinging for 4 min. Thereafter. 2 mCi of thallium-201 was
injected intravenously through the indwelling catheter. Ac-
tive leg-swinging exercise was continued for an additional
2 min . Patients were continuously monitored for any cardiac
and noncardiac side effects, including chest pain, nausea,
flushing, light-headedness, headache and dizziness . Short-
acting sublingual nitroglycerin and parenteral aminophylline
were available to reverse persistent side effects
. Cardiac
medications were not interrupted before the dipyridamole
infusion . Methylxanthines were withheld for 48 h before the
study. We previously found (32) no significant increase in the
incidence of noncardiac or cardiac side effects among elderly
patients undergoing dipyridamole thallium imaging at our
institution . In the current study of patients >70 years of age,
the same observation held true . A total of 39 patients (11%)
required aminophylline for reversal of symptoms or signs of
myocardial ischemia. However, there were no prolonged
episodes of ischemia and no myocardial infarction . severe
hypolension or death .
Thallium-101 imaging and analysis. Planar thallium-201
imaging was performed within 5 min after injection by using
a small field of View gamma camera (APEX model 215M .
Elscint Corporation) equipped with a low energy. high
resolution, parallel hole collimator . Sequential images were
obtained in the anterior, 45° left anterior oblique and left
lateral views . Images were acquired at the 80-keV photo-
peak with 20% window and stored on a 256 x 256-byte
computer matrix. Approximately 500,000 counts were ac-
quired during each 10-min image (30,31) . Redistribution
images were obtained in the same views 4 h after infusion .
Images were analyzed by two observers without prior
knowledge of the patients' clinical history or angiographic
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results
. Discordant results were adjudicated by consensus
opinion and evaluation of quar,titatively determined thallium
activity washout curves
(22) . Thallium images of the left
ventricle were divided into fve approximate regions for each
view (33). Each segment wcs scored as normal or as having
a reversible or fixed thallium defect . Thalliam scans with a
reversible
. fixed or combined (reversible and fixed) defect
were classified as abnormal for subsequent statistical analy-
sis of their prognostic value . The number of abnormal
thallium segments was ciassified as 0 to 2. 3 to 5 and >5
segments for each set of radionuclide images for cardiac risk
assessment .
Fallow-up procedure . Clinical follow-up information was
obtained through a telephone interview or a medical clinic
visit . The protocol was approved by the Institutional Review
Board of the university and written informed consent was
obtained before each procedure . During each patient or
family member contact, the following clinical events were
ascertained: the occurrence of cardiac death, noncardiac
death. nonfatal myocardial ip arction or a revascularization
procedure (pereutaneous transluminal coronary angioplasty
or coronary artery bypass graft surgery) 53 months (early)
or >3 months (late) after the dipyridtimote teat date . Inter
ventional strategies performed within 3 months of the dipyr-
idamole test date were considered to be potentially influ-
enced by the index test results and are classified as distinct
from those occurring outside the 3-month period (22) . The
cardiac event rate was defined as the occurrence of con-
firmed cardiac.  death or nonfatal myocardial infarction . The
initial cardiac event was considered the significant clinical
end point for subsequent data analysis in all cases
. Docu-
mentation of cardiac death, noncardiac death, nonfatal myo-
cardial infarction or a revascularization procedure was con-
firmed in all cases by subsequent medical chart review or
telephone contact with the referring physician.
Statistical analysis . Multivariate and stepwise logistic re-
gression analyses were performed by using clinical and
radionuclide variables to detect significant differences in
event rates (Table 1) (34). Relative risk ratios were calcu-
lated for those variables found to be statistically significant
in the stepwise regression analysis (34). Actuarial event-free
rates were analyzed by using Mantel-Breslow survival
curves (35) .
Confidence intervals for binomial proportions
were calculated
yearly
for each of the survival analysis
groups (34)
. Differences in event rates were calculated by
using the log-rank statistic over the duration of the follow-up
period (36) . Frequencies were compared with chi-square
analysis, The number of abnormal thallium-201 segments
was compared with the incidence of cardiac death or non-
fatal myocardial infarction by a one-way analysis of vari-
ance
. A p value < 0.05 was considered statistically signifi-
cant
. For repeat regression analysis modeling, a p value of
0.05 divided by the number of independee' :omparisons was
used as the level for statistical rejection .
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p
< 0 .0: comparing the groups with and without cautiac death a •
nonfatal myocardial infarction (Death or MIT . All data are expressed as mean
value z SD or as a percent . CABG = coronary artery bypass graft surgery :
C14F = congestive he .. failure .
Results
Follow-up data. The overall cardiac event rate in the 348
patients was 22% over the 23 ± 15-month follow-up period :
52 cardiac deaths, 24 nonfatal mync )dial infarctions and 24
early and 18 late revascularizatior. procedures . The 18 late
procedures comprised coronary angioplasty performed in 7
patients and coronary bypass surgery performed in I I pa-
tient's 23 months after testing .
Comparative clinical and radionuclide imaging character-
istics of patients with cardiac death or nonfatal myocardial
infarction during the follow-up period are presented in Table
l . The 2-year cardiac event rate was greater in patients with
than in those without a prior myocardial infarction (27% vs .
12%, p = 0.02) (Fig . I) . Symptoms of congestive heart
failure at presentation increased the risk of cardiac death and
nonfatal myocardial infarction (35% vs . 15% at 2 years, p =
0.001) (Fig. 2) . The incidence of cardiac death and nonfatal
myocardial infarction was greater in patients receiving digi-
talis therapy (27% vs. 14% at 2 years, p = 0
.05)
.
Dipyridamole Thallium-201 Imaging
ST segment depression ?I mm after dipyridamole infu-
sion occurred in 26 patients (7 .5%), with no significant
differences recorded in the cardiac event rates between
those with or without ischemic ECG changes (Table 2) .
Dipyridamole-induced chest discomfort was documented in
52 patients (15%) . Cardiac event rates were significantly
greater in patients with dipyridamole-induced chest pain
than in those without such symptoms (Table 2) .
-- NO Pace UI
Picrxn
S%C.I .
0.0003
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Figure 1 . The actuarial event-free survival rate was significantly
better for the 146 patients without a prior myocardial infarction (Ml)
than for the 102 patients with a history of infarction . The p values
represent significance levels for differences in cardiac event rates
over the total duration of follow-up study . C.1. = confidence
interval .
Normal versus abnormal dipyridnmoe thallium-201 scan
ensuits. Of the 149 pat .-uts with normal findings on a dipyr-
iciamote thallium-201 scan, only 3 (2%) had a fatal cardiac
event compared with 48 (24%) of 199 patients with an
abnormal scan result (p < 0 .001) . The overall cardiac event
rate (cardiac death or nonfatal myocardial infarction) was
5% (7 of 149) for patients with a normal scan result versus
35% (69 of 199) for patients with an abnormal result (p <
0 .001) . Of the seven patients who had a cardiac event, five
had documented atherosclerotic disease in the carotid, renal
or peripheral vessels . The other two patients had symptoms
of congestive heart failure at presentation : one patient had a
diagnosis of hypertrophic cardiomyopathy and one had
echocardiographically documented mitral regurgitation .
Fixed versus reversible thallium defect. Of the 199 pa-
tients with an abnormal thallium-201 scan result, 71 (20%),
69 (20%a) and 59 (17%) patients, respectively, had fixed only,
reversible only or a combined (fixed and reversible) thallium-
201 defect (Table 2) . The event-free survival rate was
significantly lower in patients with an abnormal than in those
with a normal thallium scan result (p < 0.001) (Fig . 3). When
event-free survival rates are compared according to type of
defect, patients with a combined defect had the lowest
event-free survival rate (p < 0.001) (Fig . 4)
. Patients with a
fixed or reversible defect had an intermediate event-free
survival rate, with some overlap in confidence intervals
between the two groups (p < 0 .001) .
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Table 1, Clinical Characteristics of 348 Patients 070 Years of Age 100-
Death
o, nn
In = 76)
No Death
or MI
(n = 2721
Toll
0n = 348)
Mean age (yr) 7504 7504 75!4
a0
so-
Mean follow-up duration (mo) I8 0 )4` 24 s 15` 23 0 15
Men (no .) 42 (55%) 131 (48%) 173 (507,)
Z
Asymlnometic (no .) 25 13791 116 (43% I 141(41%)
6a-
Atypical chest pain (no .) 7 (9%r
.(22V
67 (19%)
Symptoms ofCHF (no .) 18(24701` 27009, 1` 45 (!3%I
4
Typical angina (no.) 26(34%) 69(25%) 95 (27%)
Previous CABU (no.)
Previous MI (no.)
5 n%)
36(47%1%
27 1 7:
66124%I` ;02(29%I
c
m
i
40-
Diabetes melliws (no.) 23 (30%)' 57(21%)* 80(23 17)
W
Hypercholeslerolemia (no.) 8(10%) 62(23%)" 70(20%)
Hypertension
In .
.) 4205%) 155 (579) 197(57%)
E
History of cigarette smoking (no .) 14(18%) 43)16%) 57 (16%)
t3
2o-
Beta-blocker Ihereoy (no) . 16(21%) 44 (16%) 6007%)
Calcium antagonist therapy (no .) 34 (45%I 101 (37%I 135 (397,1
D!g!lalis therapy (no.) 29 (3891` 60 (2291` 89(26%I
Nilrme Therapy (nn.) 13 (43%) 106 (399,) 139)40%)
0
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Figure 2. The actuarial event-free survival rate was significantly
better for the 303 patients without symptoms of congestive
two"failure (CHF) at presentation than for the 45 patients with such
symptoms . The p values represent significance levels for differences
in cardiac event rates over the total duration of the follow-up study .
C.I . = confidence interval
.
To assess the prognostic impact of the extent of defect,
the cardiac event rate was compared with the number of
abnormal thallium-201 segments . Patients with <2, 3 to 5
and >5 abnormal myocardial segments had, respectively, an
event rate of 13%, 48%, and 40% at 2 years. (p < 0.001) (Fig
5) .
Coronary revascularization . A total of 112 patients under-
went coronary angiography within 6 months of the index test
date; 42 of these underwent a coronary revascularization
procedure, including 3 with normal and 39 with abnormal
Table 2 . Dipyridamole Thallium-201 Findings in 349 Patients <70
Years of Age
'p < 0.05 . SBP= systolic blood pressure: other abbreviations as in Ta-
ble 1 .
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Figure 3 .
The actuarial event-free survival rate was significantly
better fur the 149 patients with a normal thallium-201 ff1-201) scan
result than for the 199 patients who had an abnormal scan result .
C .1. _ confidence interval .
thugs on a thallium-201 scan. Among the latter 39 patients,
24 underwent their revascularization procedure within 3
months of the intravenous dipyridamole scan
.
Coronary surgery . Of the 42 patients receiving surgical
therapy . 71% had a reversible or combined thallium-201
defect and 21% had a fixed defect only
. The mean number of
abnormal thallium defects was significantly greater in the 17
patients receiving late revascularization than in the 306
patients who did not undergo a surgical procedure (4 .4 ± 3 .4
vs . 2 .3 - 2 .5, respectively, p < 0.001). The 30-day operative
mortality rate was 7% (3 of 42) . One patient died of renal
failure and sepsis after coronary bypass surgery
. A fatal
myocardial infarction and death secondary to congestive
heart failure were recorded in the other two patients .
Univariate and Multivariate Analyses
Univariate analysis. Before statistical modeling was initi-
ated, univariate regression analysis was utilized to determine
significant predictors of cardiac events (Table 3) . Significant
variables included an abnormal thallium-201 defect (com-
bined, fixed or reversible), prior myocardial infarction,
symptoms of congestive heart failure, number of abnormal
segments an thallium testing, presence of atypical chest
pain, digitalis therapy, hypercholesterolemia and a history of
diabetes mellitus .
Multivarlate logistic regression analyses . All significant
univariate predictors were then entered into the regression
model to detect independent predictors of cardiac death or
Death
or MI
In =76)
No Death
or MI
In-2721
Total
In - 348)
Dipyridnmale-irduced
ST depression
-1 mm (no
.)
7(99x) 1917%)
26 (7
.5%)
Dipyridamvle-induced chest pain
(no.)
17(221/,) 35113%1' 52(157,)
SBP decrease 0 20 mm Hg Ino.)
Thallium-201 scan results
(no .)
13117%) 561219%
69 (21y/)
Normal scan 70%) 142(52%1- 149143%)
Fixed defect
22129%)
49(18%I'
71(204)
Reversible defect 22(29%)
47(17%1'
69120%)
Cemhineddefect 25(53%) 34)13%)' 39117%)
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Figure 4 . The actuarial event-free survival rate was significantly
better for patients with a normal thallmm-201 scan result than fur
patients with a fixed, reversible or combined thallium-201 defect .
The event rate was greatest in patients with a more extensive
(combined) defect (p < O .00I) . C .1. = confidence interval .
nonfatal myocardial infarction . Results from multivariate
stepwise logistic regression analysis of clinical and radionu-
elide imaging variables revealed three variables that were
significant predictors of a cardiac event . An abnormal that.
lium-201 scan result was the single best predictorof a cardiac
event (p < 0 .001). Patients with an abnormal scan result
were 7 .2 times more likely than patients with a normal result
to have a cardiac event . Symptoms of congestive heart
failure at presentation (odds ratio 2
.1 . p = 0.01) and a history
of myocardial infarction (odds ratio 2 .2, p < 0
.001) were
independenay associated with a greater risk of a cardiac
event than that of patients without this clinical history .
On the basis of results from univariatc and stepwise
analysis, various multivariate models for prediction of car-
diac events were used to simulate a clinical spectrum of
patient characteristics (Table 4) . Symptoms of congestive
heart failure alone predicted only 23 .7% of the cardiac
events (p = 0 .001) compared with prior myocardial infarc-
tion, which predicted 47% of cardiac events (p < 0-001) . By
type of thallium-201 defect, the predictive power of thallium
imaging was 33% in patients with a combined thallium defect
(odds ratio 2 .3, p < 0 .001), 29.7% for those with only a
reversible defect (odds ratio 1,6, p = 0.02) and 293% for
patients with only a fixed defect (odds ratio 1 .6, p = 0 .03).
When combined variables were examined, evidence of
reversible myocardial hypoperfusion, as documented by a
reversible or combined thallium-201 defect, predicted 60 .5%
of cardiac events (p < 0.001) . The cumulative power for
prediction of a cardiac event was cr?styts
in
!I i
r^e nS
any abnormal thallium defect alone (90 .7%, p < 0 .001), an
abnormal thallium defect plus the presence of congestive
heart failure (92%, p < 0.001), or a prior myocardial infarc-
tion (92%, p < 0 .001) .
Discussion
Previous studies. Althoh, ;h the diagnostic utility of dipyr-
idamole thallium-201 myocardial imaging has been investi-
gated in many patient subsets, previous studies (23-31) hove
not specifically focused on the prognostic value of this
noninvasive test in the elderly . We previously reported (32)
that intravenous dipyridamole thallium imaging is safe in the
elderly patient, with sensitivity and specificity values com-
parable to those in younger patients . Prognostic
thallium-201
imaging data in older age groups have almost exclusively
focused on older patients, using 65 years as the cut point and
exercise as the stress (13,20) .
Investigations (23-31) of the prognostic significance of
dipyridamole thallium-201 imaging in patients with inade-
quate exercise tolerance have isolated various clinical and
radionuclide imaging variables associated with a worse out-
come. Age has been reported (29,31) to be a significant
univariate predictor for cardiac events, including cardiac
death, nonfatal myocardial infarction or revascularizat)on
procedure. Multivariate analysis of clinical and intravenous
dipyridamole thallium-201 imaging data in patients undergo-
Figure 5 . The actuarial event-free survival rate was significantly
better for the 159 patients with 0 to 2 abnormal thallium-201
Segments than for the 189 patients with z3 abnormal segments .
C .1 . = confidence interval .
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Table 3 . Univariate Predictors of Cardiac Death or Nonfatal
Myocardial Infarction in 346 Patients a70 Years of Age
10 year,) in patients with a cardiac event in an unselected
patient series (27) was significantly older than that (64 ± 11
yearsl in patients who had no cardiac event after a mean
follow-up interval of 21 months.
Because advanced age characterizes a large proportion of
the patients referred for clinical assessment and a large
number of patients referred for dipyridamote thallium-201
testing. the impact safe these results in elderly patients with a
high risk of coronary artery disease and theoretically limited
survival is uvorthy of investigation.
Nearly 22% of patients in our 348-patient series experi-
enced a cardiac event during a mean 23-month follow-up
period, a higher rate than that recorded in younger study
groups (27-31) . For example, in the series of Hendel et at .
(27), the cardiac event rate in a younger age group was only
10%r . In 539 patients with a mean age of 54 ± 8 years. Picano
et al . (29) reported a 22% event rate after 3 years of
follow-up
. even though revascularization procedures were
included as cardiac end points
. In our elderly patients,
revascularization procedures were not included in the over-
all cardiac event rate but occurred in an additional 12% of
patients .
Risk stratification by clinical and radionuclide imaging
results
. The best predictors
of
cardiac death or myocardial
infarction were the presence of a thallium-201 defect, symp-
toms of congestive heart failure and a previous myocardial
infarction (all p < 0.001). In patients with a prior history of
ing major vascular surgery has identified age >70 years as a
typical angina or previous myocardial infarction, a reversible
significant predictor of postoperative cardiac events (25) . 1n
thallium defect has been reported (23-25,28) to be a powerful
the postoperative series of Eagle et al . (25). nearly 50%0 of
predictor of an adverse outcome, as defined by events such
the patients having a postoperative in-hospital ischemic
as perioperative cardiac death, myocardial infarction, unsta-
event were >70 years of age. In addition, the mean age 1,67 t
ble angina or ischemic pulmonary edema. Lower survival
Table 4. Incremental Value of Clinical and Radionuclide Variables for the Prediction of Cardiac
Death or Nonfatal Myocardial Infarction in the 348 Patients >70 Years of Age
Abbreviations as in Tables I and 2.
Abnormal = abnormal thallium-201 perfusion defect, CM = combined fixed and reversible thallium-210 perfusion
defects : RV = reversible thallium-201 perfusion defect
: other abbreviations as in Table I .
No .
1/1
Predicted
Relative
Risk
P
Value
CHF symptoms 45 23 .7 2 .2 0.001
Fixed defect 71 29.3 1 .6 0.03
RV defect 70 29.4 1 .6 0
.02
CM defect 59 32 .0 2 .3 <O.OD1
Previous MI 102 47.0 2 .1 <0
.001
RV defect + CHF 102 42.0 1 .8 0
.004
Fixed defect + CHF 104 46.0 2 .5
<0.001
CM defect + CHF 96 50.0 2 7 <0.061
CM defect + prior MI
131 59.2 25 <O .CUI
RV or CM defect + CHF 126
60.5 2.6 <0 .001
Fixed defect + prior Ml 146 61 .8 2 .7 <0.001
RV or CM defect + CHF 151 63.5 2.9 <0
.001
RV defect + prior MI 150 64.5 2.5 <0 .0D1
RV or CM defect + prior MI 176 66.7
3
.3
<0 .001
Abnormal defect 199 90.7
7.2 <0 .001
Abnormal defect + CHF 21, 92.0 7.3
<0
.001
Abnormal defect + prior MI 223 92.0 6.4 <0 .001
Chi-Square pValue
Clinical variables
Previous Ml 16 .06 <0,001
CHF symptoms 10 .94 0.001
Atypkal cheat pain
7 .54
0.006
Digitalis therapy 11 .25 0007
tlypercholesterolemia 5 .31 0.02
Diabetes mellitus 3 .12
0
.05
Typical chest pain 2.56 0 .11
Aeymptomatic 2.11 0.15
Gender 1 .44 0.23
Beta-blocker therapy 1 .09 0.29
Previous CABG 0 .75 0.39
ifstory of cigarette smoking
11 .35
0 .49
Age 0 .20 0 .63
Hypertension 0 .02 0.97
Family history D01 0 .93
Radionuclide variablo
Abnormal thallium 201 scan 43.42 <0 .001
Combined defec, 15.96 <0.001
No. of abnormal segments 10.36 0.003
Reversible defect only 499 0.02
Fixed defect only 4.63 0.03
Dipyndamole ST depression 0.47 019
SBP decrease >20 mm Hg 0.39 0.55
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rates have been reported (37) in patients referred for nonin-
vasive testing who have congestive heart failure than in
flwsa nittl tic A, minimal svrnptonls . By combining the
power of significant clinical and scintigraphic predictors in
our study, it was possible to account for nearly all of the
events documented . Patient stratification into low and high
risk subgroups could be performed on the basis of presence
or absence of these independent variables . The presence ci
any thallium-201 perfusion abnormality had a greater predic-
tive accuracy than did clinical characteristics or the type of
perfusion defect . Slightly >90% of cardiac deaths or nonfatal
myocardial infarctions occurred in patients with a thallium-
201 defect (any type) . The incremental increase in the
prediction of cardiac events after the addition of clinical
variables was small . However, the power of clinical varia-
bles may have been underestimated because clinicians pre-
select patients for intravenous dipyridamole thallium-201
testing who are considered to be at increased clinical risk .
thus increasing the probability of subsequent abnormal test
results and cardiac events.
In our elderly patients with a normal thallium-201 perfu-
sion study result, only 5% had a cardiac death or a nonfatal
myocardial infarction during a 23 ± 15 month follow-up
period. When additional clinical variables were considered,
a higher risk subset of patients with normal thallium-201
imaging could be identified by the association of symptoms
of congestive heart failure or concomitant atherosclerotic
disease. Younis et al . (3t) reported a similarly low incidence
of cardiac death or nonfatal myocardial infarction in asymp-
tomatic patients (average age 63 ± 12 years) with previously
documented coronary artery disease referred for intrave-
nous dipyridamole thallium imaging ; some of these patients
are included in the present series . In this earlier study of
younger patients (31), no deaths or myocardial infarctions
occurred during the 14 ± 10 months of follow-up in patients
with a normal thallium scan result
.
Actuarial survival analysis revealed that the extent of the
thallium-201 defect was predictive of a lower survival rate .
Several investigators (25,27,38) have identified patients with
0 to I abnormal myocardial segments on thallium testing as
a low risk cohort not associated with a high rate of cardiac
events
. In our large series of elderly patients, a low risk
myocardial perfusion scan was defined as a defect involving
<3 abnormal myocardial segments on thallium testing
. The
cardiac event rate was significantly greater in patients with
W3 abnormal myocardial segments.
Limitations of the study. When study entry is limited to a
retrospectively identified series of patients, a causal relation
between abnormal test results and the incidence of cardiac
events is difficult to infer without
significant
attention to
influential covariales, Because study entry was limited only
by age, numerous clinical variables that could have affected
the study results may not have been accounted for in the
statistical analyses .
Repeat statistical analyses were utilized to determine
important patient and radionuclide characteristics associated
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with an adverse event . Repeat analysis holding the level of
significance at the 0.05 level increases the probability of a
type I error . For repeat regression analysis modeling, a p
value of 0.05 divided by the number of independent compar-
isons was used as the level fur statistical rejection.
Data collection from a single institution is influenced by
patient referral patterns and limits the general applicability
of study results to varied institutions . The generalizahility of
study findings may be slightly different if patient entry
criteria differ significantly from those of the patients included
in this study . The supply of intravenous dipyridamole was
limited before the use of this drug was approved by the Food
and Drug Administration . Despite this, our data were col-
lected from a large and heterogeneous group of patients, and
the results should be applicable to an unselected group of
elderly patients.
Five percent of patients were unavailable for follow-up
study . Although inclusion of results from this missing group
could affect overall study results, the clinical and radionu-
clide characteristics of those patients lost to follow-up were
typical of the current study group . Quantitative imaging
might have increased the sensitivity for detection of the
subtle redistribution over that achieved by qualitative inter-
pretation alone .
Relation to previous studies. The study group comprised
patients referred for evaluation of known or suspected
coronary artery disease on the basis of presence of symp-
toms (atypical chest pain 19%, typical angina 27%), prior
history of myocardial infarction (29%) or coronary revascu-
larization (9%) and previous coronary angiographic results .
This group represents t a spectrum of patients, including
those undergoing preoperative evaluation and postinfarction
risk stratification . As such, the data cannot be directly
compared with those of previous studies limited to either the
preoperative or the postinfarction use of dipyridamole that-
lium-201 imaging for risk stratification.
With one exception (39), this and previous observational
studies (23-28,30) have demonstrated a significantly in-
creased risk for cardiac events in association with the
presence of dipyridamole-induced thallium-201 redistribu-
tion . Despite the high negative predictive value of dipyrida-
mole thallium stress imaging for subsequent cardiac events
(82% to 100% in preoperative screening), the positive pre-
dictive value of thallium-201 redistribution for subsequent
events is much lower (27% to 58%) (39).
The prognostic
value ofdipyridamole thallium-201 imag-
ing is influenced by several factors : the patient group,
method of perfusion scan interpretation, access of clinicians
to test data- the definition of cardiac events utilized and
interventions (if any) to reduce risk based on the results of
the test . Sbsdics performed in tertiary referral centers may
not be applicable in medical facilities with a different referral
base, scan interpretation method or clinical intervention
strategy . The initial report (23) of preoperative cardiac risk
defined by dipyridamole thallium imaging and the most
recent comparable study (39) evaluated a similar number of
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patients (48 vs . 60) but derived significantly different out-
comes despite a comparable occurrence of dipvridamole-
induced thallium redistribution (33'% vs . 37%) . In the 6-year
period between the publication of these two important
studies, significant evolution has occurred in patient selec-
tion and referral patterns for dipyridamole thallium-20t
imaging and in the management of patients based on the
results of this preoperative screening procedure .
Our elderly study group comprised a consecutive series
of patients and was larger than that in most previous reports ;
it provided data on the value of dipyridamole thallium-201
stress imaging derived from a wide referral base (inpatients
and outpatients) studied over several years with a spectrum
of presenting clinical syndromes . Consistency of scan inter-
pretation technique by the use of the same expert observers
should theoretically have minimized technical and observer-
based variability in our study . The results of dipyridamole
thallium data were made available to clinicians and were
integrated into the decision to perform subsequent coronary
revascularization in 42 patients (12%), despite the advanced
age of this group. Although the study was not performed in
blinded fashion and modifications were made, as anticipated,
in medical and surgical management on the basis of study
results, 52 cardiac deaths and 24 nonfatal myocardial infarc-
tions were observed after a mean follow-up period of 2
years. This "hard" cardiac event rate (I1%/year) is compa-
rable to previous event rates in preoperative dipyridamole
thallium-201 studies (54 [9 .4%I of 575) (40) and after myo-
cardial infarction (22 (15.6%] of 141) (26,28,41) . The hard
cardiac event rate in one recent "negative" study (39) was
5% (3 of 60 patients), highlighting the potentially confound-
ing effect of differences among study groups .
The current study identified the presence of any fixed or
reversible dipyridamole thallium-201 defect as a powerful
predictor of subsequent cardiac events (relative risk 7 .2) .
The previously documented (42) risk of recent myocardial
infarction and coexisting congestive heart failure was con-
firmed in this study, but added little to the relative risk above
that associated with a perfusion defect alone The presence
of a fixed or combined (fixed and reversible) perfusion defect
was found to be at least as predictive of subsequent cardiac
death or myocardial infarction as was a reversible perfusion
defect, an observation similar to that in previous reports
(39,43). Clearly, fixed defects with the potential for late
(>4 h) redistribution may also contribute to the risk of
subsequent adverse ischemie cardiac events, although this
finding was not evaluated in the current study .
Ctitlical versus scintigraphic risk stratification . It is clear
from this and previous studies (25) that a combined clinical
and perfusion imaging assessment optimizes risk stratifica-
tion, regardless of the clinical setting. The most cost-
effective approach to preoperative risk stratification may be
initial clinical classification into high, moderate and low risk
categories, with subsequent angiography frequently required
in clinically high risk patients and no further evaluation
needed in low risk patients (44). In this algorithm, the
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presence of prior myocardial infarction and congestive heart
failure (two factors identified in the current study) . diabetes
mellitus and angina pectoris was a clinical high risk marker .
One additional clinical risk marker, age >70 years, was
utilized to define our study group. As such, all patients in the
current study would have at least one clinical high risk
variable (44) and would be in a moderate risk category in
which the presence or absence of thallium-201 redistribution
defines the likelihood of subsequent cardiac events . By
applying this clinical-scintigranhic approach, dipyridamole
thallium redistribution has been associated with a t0-fold
increase in the risk of perioperative cardiac events (29 .6%
vs . 3 .2%) (25,44).
It is reasonable to conclude that elderly (w70 years)
patients are at least a moderate risk patient group, even in
the absence of prior myocardial infarction or congestive
heart failure . The prognosis of these patients can be defined
further with dipyridamole thallium-20I imaging . Prospective
studies are required io determine whether subsequent man-
agement modifications based on this assessment will modify
outcome in elderly patients with coronary heart disease .
Conclusions, Advanced age has been correlated with an
increased risk of cardiac events . The purpose of this study
was to investigate the prognostic utility of intravenous
dipyridamole thallium-20l myocardial imaging in patients
z70 years of age . Our study indicates that intravenous
dipyridamole thallium myocardial imaging results are highly
predictive of cardiac events in the elderly . In particular, the
subsets of elderly patients with an abnormal thallium scan
result and a previous myocardial infarction or a prior history
of congestive heart failure were at greatest risk for cardiac
death or nonfatal myocardial infarction
. A normal dipyrida-
mole thallium study result, irrespective of a previous history
of myocardial infarction, was associated with a highly favor-
able survival rate, particularly in the absence of concomitant
noncardiac atherosclerotic disease or congestive heart fail-
ure . The data extend the results of
dipyridamole and exer-
cise stress thallium-201 studies in younger age groups to the
growing number of elderly patients who are frequently
unable to exercise maximally but remain at significant risk
for cardiac events.
We thank Mary Streif and Lod Gallini Meeker for secretarial assistance.
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